GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CurveBeam AI Ltd (ASX:CVB) » Definitions » Notes Receivable

CurveBeam AI (ASX:CVB) Notes Receivable : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is CurveBeam AI Notes Receivable?

CurveBeam AI's Notes Receivable for the quarter that ended in Dec. 2023 was A$0.00 Mil.


CurveBeam AI Notes Receivable Historical Data

The historical data trend for CurveBeam AI's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CurveBeam AI Notes Receivable Chart

CurveBeam AI Annual Data
Trend Jun21 Jun22 Jun23
Notes Receivable
- - -

CurveBeam AI Semi-Annual Data
Jun21 Dec21 Jun22 Jun23 Dec23
Notes Receivable - - - - -

CurveBeam AI Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


CurveBeam AI Notes Receivable Related Terms

Thank you for viewing the detailed overview of CurveBeam AI's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


CurveBeam AI (ASX:CVB) Business Description

Traded in Other Exchanges
N/A
Address
10?16 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the Company's CT devices to assist in the clinical assessment and management of musculoskeletal health conditions, with a focus on orthopedic and bone health issues. The Company is the first to market with natural bilateral weight-bearing and non-weight-bearing CT, point-of-care imaging equipment with targeted proprietary AI solutions.

CurveBeam AI (ASX:CVB) Headlines

No Headlines